Target intelligence / Profile preview

microRNA 520d (miR-520d)

Target
miR-520d
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

microRNA 520d (miR-520d; also designated as hsa-miR-520d) is a small, non-coding RNA molecule from the microRNA family that regulates gene expression by binding to target mRNAs, promoting their degradation or repressing translation. It is particularly implicated in the regulation of chondrogenic differentiation of human mesenchymal stem cells and chondrocyte metabolism—mainly via direct inhibition of HDAC1—and plays a role in diverse cellular functions such as proliferation, differentiation, senescence, and apoptosis. Dysregulation of miR-520d has been reported in cancer (glioma, colorectal), osteoarthritis (affecting cartilage health), and neurodegenerative disorders (such as Parkinson's disease), suggesting its utility as a biomarker and a putative therapeutic target, though no drugs currently target it directly[1].

Other names
hsa-miR-520dMIR520Dhsa-mir-520dMIRN520DmiR-520d-5pmicroRNA-520d-5p
02

Mechanism of action

Targets and inhibits mRNAs via binding to their 3’ untranslated regions (notably HDAC1 mRNA in chondrogenesis) [1]

03

Biological functions

Regulation of gene expression (post-transcriptional gene silencing)Cell differentiation (notably chondrogenesis in human mesenchymal stem cells)Cell proliferationApoptosisCellular senescence and survival
04

Disease associations

Cancer (including glioma and colorectal cancer) [1]Osteoarthritis (regulation of chondrogenesis and cartilage metabolism) [1]Neurodegenerative disease (reported upregulation in serum of Parkinson’s disease patients) [1]
05

Safety considerations

Therapeutic targeting of microRNA pathways may have off-target or pleiotropic effects due to broad gene regulatory roles; clinical safety is not established [1]
06

Interacting drugs

None directly reported; however, CI994 (tacedinaline), an HDAC1 inhibitor, targets a downstream effector of miR-520d-5p-regulated pathways (indirect relationship) [1]
07

Biomarkers

Potential biomarker for cartilage integrity and osteoarthritis [1]Possible cancer biomarker (various tumor types)Differential levels reported in neurodegenerative diseases (e.g., Parkinson’s disease) [1]

Beyond the preview

Go deeper on microRNA 520d (miR-520d).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 520d (miR-520d).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call